Real-Time Intraoperative Metabolomics to Guide Resection Decisions

Surgical resection remains one of the most effective treatments for solid tumors. The central challenge of surgery is achieving maximal tumor removal while preserving healthy tissue and critical structures. Even with advanced imaging and magnification, tumor margins are not always visually distinct. Cancer cells often infiltrate surrounding tissue in subtle ways, making it difficult to determine exactly where to stop resection. Real-time intraoperative metabolomics offers a transformative approach by providing chemical information about tissue during the operation itself.

A standard tumor surgery begins with preoperative imaging such as magnetic resonance imaging or computed tomography to map tumor location and plan the approach. In the operating room, surgeons rely on visual inspection, anatomical landmarks, and image-guided navigation systems to remove abnormal tissue. In some cases, intraoperative imaging is used to confirm the extent of resection before closing. While these tools are powerful, they primarily provide structural information. They show where tissue is located but not how it behaves biologically.

Metabolomics introduces functional insight into this process. It is the study of small molecules known as metabolites, which reflect the biochemical activity of cells. Tumor cells often demonstrate altered metabolism, including increased glycolysis, changes in lipid synthesis, and disrupted amino acid pathways. These metabolic differences produce identifiable chemical signatures. By detecting these signatures during surgery, clinicians can distinguish tumor tissue from normal tissue based on molecular composition rather than appearance alone.

Mass spectrometry is one of the leading technologies enabling this approach. During surgery, a small tissue sample or surgical aerosol can be analyzed within seconds to minutes. The instrument generates a metabolic profile and compares it to reference databases. If the profile matches tumor tissue, resection can continue in that area. If it resembles healthy tissue, the surgeon may stop to prevent unnecessary damage. This creates a rapid feedback system that supports real-time decision-making.

Fluorescence-guided surgery represents another application of metabolism-based guidance. Patients receive compounds that tumor cells process differently, causing malignant tissue to emit visible fluorescence under specific lighting. This visual signal helps delineate tumor boundaries and complements other imaging methods.

The future of intraoperative metabolomics lies in integration and refinement. Artificial intelligence systems are being developed to interpret complex metabolic data instantly, improving classification accuracy and predicting tumor characteristics. As instruments become smaller and databases expand, these technologies may become standard components of surgical suites. Ultimately, real-time metabolomics has the potential to shift surgery from being guided primarily by anatomy to being guided by biology, enabling more precise and personalized resection decisions.

Written by Ariela Okanta at Incisionary

References

Mirnezami, R., Kinross, J. M., Vorkas, P. A., Goldin, R., Holmes, E., Nicholson, J., & Darzi, A. (2012). Implementation of Molecular Phenotyping Approaches in the Personalized Surgical Patient Journey. Annals of Surgery, 255(5), 881–889. https://doi.org/10.1097/sla.0b013e31823e3c43

Saoi, M., & Britz‐McKibbin, P. (2021). New Advances in Tissue Metabolomics: A Review. Metabolites, 11(10), 672–672. https://doi.org/10.3390/metabo11100672

Seymour, K. A., Strain, M., Ashley-Koch, A., Muehlbauer, M. J., Ilkayeva, O. R., George, T. K., Hill, D., Ellison, M., Ito, S., Lagoo-Deenadayalan, S., Plichta, J. K., Purves, J. T., Thacker, J. K. M., Nalley, J., Kirk, A. D., Hwang, E. S., & Bain, J. R. (2024). Acute perioperative alterations in metabolism: A pilot study using mass spectrometry–based metabolomics. Surgery, 180, 109055. https://doi.org/10.1016/j.surg.2024.109055

Sirkin, N. J., Harper, T., Lamey, E., Wilhelm, J. N., Rought, G., & Yerrapragada, A. (2026). Intraoperative metabolomic-guided precision surgery for pediatric brain tumors: A systematic review of multi-modal molecular imaging platforms and artificial intelligence integration. MedRxiv. https://doi.org/10.1101/2025.09.26.25336769

Vintimilla Rivadeneira, V., & Leon-Rojas, J. E. (2025). Advances in Preoperative and Intraoperative Technologies for Safe Resection of Gliomas in Cognitive Regions. Cancers, 17(24), 3890. https://doi.org/10.3390/cancers172438900.3390/biomimetics10120818